Cargando…
In vivo studies of a peptidomimetic that targets EGFR dimerization in NSCLC
Studies related to lung cancer have shown a link between human epidermal growth factor receptor-2 (HER2) expression and poor prognosis in patients with non-small cell lung cancer (NSCLC). HER2 overexpression has been observed in 3-38% of NSCLC, while strong HER2 protein overexpression is found in 2....
Autores principales: | Shrestha, Leeza, Singh, Sitanshu S., Parajuli, Pravin, Dahal, Achyut, Mattheolabakis, George, Meyer, Sharon, Bhattacharjee, Joydeep, Jois, Seetharama D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477407/ https://www.ncbi.nlm.nih.gov/pubmed/32922539 http://dx.doi.org/10.7150/jca.46320 |
Ejemplares similares
-
Targeting protein–protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model
por: Dahal, Achyut, et al.
Publicado: (2022) -
Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
por: Naik, Himgauri, et al.
Publicado: (2021) -
Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications
por: Sable, Rushikesh, et al.
Publicado: (2017) -
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization
por: Kanthala, Shanthi P., et al.
Publicado: (2017) -
EGFR trafficking: effect of dimerization, dynamics, and mutation
por: Schultz, Destiny F., et al.
Publicado: (2023)